Product Information

LABETALOL HCL 100 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0850 per EA under NDC 68382079801. Its NADAC has been published 433 times since May 9, 2018.

FDA first approved this application on Sep 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LABETALOL HCL 100 MG TABLET

Labetalol Hydrochloride
$0.0850per EA

Strength

100 mg/1

NDC

68382079801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207743

FDA Approved

9/19/2017

TE Code

AB

On Market Since

12/5/2017

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for LABETALOL HCL 100 MG TABLET has been published 433 times since May 9, 2018, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0850 per EA
All-time high$0.2113 (Jun 13, 2018)
All-time low$0.0789 (Mar 18, 2026)
52-week high$0.0852
52-week low$0.0789
Median price$0.1209
Average price$0.1255
Largest weekly change+34.4% (Jun 19, 2024)
Weeks tracked433
Tracking sinceMay 9, 2018

Price History

1W

+4.0%

1M

+4.0%

3M

+5.3%

6M

+2.4%

1Y

-0.2%

3Y

-22.8%

5Y

-43.9%

All

-56.8%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LABETALOL HCL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0850 per EA (NDC 68382079801), effective Aug 19, 2026.

How has the price of LABETALOL HCL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LABETALOL HCL 100 MG TABLET has declined 56.8%. It has been tracked across 433 weekly CMS publications since May 9, 2018.

What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG TABLET?

Since May 9, 2018, the NADAC for LABETALOL HCL 100 MG TABLET has ranged from a low of $0.0789 (Mar 18, 2026) to a high of $0.2113 (Jun 13, 2018), with a median of $0.1209 per EA.

Are there cheaper alternatives to LABETALOL HCL 100 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LABETALOL HCL 100 MG TABLET, is $0.0807 per EA — about 5% below LABETALOL HCL 100 MG TABLET.

Who manufactures LABETALOL HCL 100 MG TABLET?

LABETALOL HCL 100 MG TABLET (NDC 68382079801) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.